CELAVERSE, LLC – Trademark Portfolio
Entity Type: 16
CELAVERSE, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include CELAVERSE and THE UNIVERSE OF CELEBRATIONS!. The owner is based in Palmetto, GA.
22 COR 009
6719 Jules Trace
Palmetto, GA 30268
Showing of trademarks Trademarks
Trademark Classifications
CELAVERSE, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CELAVERSE, LLC have?
CELAVERSE, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending, 1 abandoned.
What trademark classes does CELAVERSE, LLC file in?
CELAVERSE, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are CELAVERSE, LLC's most well-known trademarks?
CELAVERSE, LLC's registered trademark portfolio includes well-known marks such as CELAVERSE and THE UNIVERSE OF CELEBRATIONS!. These are among 2 currently registered trademarks in the portfolio.
What is CELAVERSE, LLC's trademark registration success rate?
CELAVERSE, LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.